Concert Pharmaceuticals to Participate on a Private Company Panel at the Merriman Curhan Ford 6th Annual Investor Summit
|
|
|
| Posted
:
Tue, 03 Nov 2009 12:32:37 GMT |
| Author
:
Concert Pharmaceuticals, Inc.
|
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
| Press Release
News |
Home
|
|
|
|
LEXINGTON, Mass. - (Business Wire) Concert Pharmaceuticals, Inc. announced today that Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will participate on the Healthcare Private Company Panel at the Merriman Curhan Ford 6th Annual Investor Summit on Tuesday, November 10, 2009 at 2:00 p.m. eastern time. The one day conference is being held at the Sofitel New York in New York City. About Concert Concert Pharmaceuticals is a clinical stage biotechnology company focused on the application of deuterium chemistry to create novel and differentiated small molecule drugs. Concert’s approach leverages known activity and safety of existing drugs to reduce time, risk and expense of drug research and development. The Company has a broad research pipeline encompassing many therapeutic areas including infectious disease and renal disease, among others. Its lead development candidate is the HIV protease inhibitor CTP-518. In 2009, Concert entered into a potential $1 billion collaboration with GlaxoSmithKline to develop and commercialize certain deuterium-containing medicines. Founded in 2006, Concert has raised more than $110 million of venture and institutional capital. For more information on Concert Pharmaceuticals, please visit www.concertpharma.com. Concert Pharmaceuticals and the CoNCERT logo are trademarks of Concert Pharmaceuticals, Inc.
Concert Pharmaceuticals, Inc.
Justine E. Koenigsberg, 781-674-5284
Senior Director, Corporate Communications and Investor Relations
jkoenigsberg@concertpharma.com
|
Copyright © 2008
Business Wire. All rights reserved.
|
|
|
|
|
Related
News
Research and Markets: Tobacco in the Netherlands
DUBLIN -
Research and Markets (
Research and Markets: The Outlook for Pharmaceuticals in Western Europe - Total Pharmaceutical Market Value to Grow to US$244.6 Billion in the Next Five Years
DUBLIN -
Research and Markets (
Research and Markets: Imaging Agents - a Worldwide Market Review
DUBLIN -
Research and Markets (
QHR Announces $1,500,000 in New Contract Business
KELOWNA, BRITISH COLUMBIA -- 11/26/09 --
QHR Technologies Inc. ("QHR" or the "Company") (TSX VENTURE: QHR) is pleased to announce that the Company's Enterprise Management Software ("EMS") division has generated in excess of $1,500,000 in new busine..
Research and Markets: Intravenous Equipment - a World Market Intelligence Report
DUBLIN -
Research and Markets (
Vast Exploration Inc.-To Present at Canaccord Adams Global Energy Conference in Miami, Florida on December 2, 2009
CALGARY, ALBERTA -- 11/26/09 --
Vast Exploration Inc. ("Vast" or "the Company") (TSX VENTURE: VST) is pleased to announce that the Company will be presenting at the Canaccord Adams Global Energy Conference at the Fontainebleau Miami Beach in Miami,..
Speedware Completes IBM Mainframe to Windows Migration for Yale New Haven Health System
MONTREAL, Nov. 26 /PRNewswire/ - Speedware Ltd., a leading provider of IT modernization solutions, today announced the successful completion of an IBM mainframe-to-Windows migration project for its customer, Connecticut-based Yale New Hav...
|
|
|
|
|
|
|
|
|
